Investigating PanNet Tumorigenesis with Single Cell Genomics
Chang Chan, PhD
Funded Research Projects
PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
PANNET Modeling, Mechanisms, and Experimental Treatment
James Bibb, PhD
NET-SMART Therapy: A Targeted Prodrug Strategy (II)
Justin Annes, MD, PhD
Molecular Influences of Racial Disparities in Pancreatic Neuroendocrine Tumors
J. Bart Rose, III, MD, MAS, FACS
Targeted alpha therapy of NETs using somatostatin-based radiopharmaceuticals with improved tumor-to-kidney ratio, the theranostic approach.
Prof. Dr. Apr. Frederik Cleeren
Mesenteric fibrosis in small intestinal neuroendocrine tumors: pathogenesis
Martyn Caplin, DM, FRCP
New models to study neuroendocrine tumors
Patricia Dahia, MD, PhD
uPAR-targeted PRRT: new radionuclide-based therapy
Andreas Kjaer, MD, PhD, DMSc
Epigenetic dysregulation of transposons in pancreatic neuroendocrine tumors
Parijat Senapati, PhD